Preclinical pharmacology and clinical efficacy of AZD9150 (ISIS-STAT3Rx), a potent next-generation antisense oligonucleotide inhibitor of STAT3 Meeting Abstract
| Authors: | Hong, D.; Kim, Y.; Younes, A.; Nemunaitis, J.; Fowler, N.; Hsu, J.; Zhou, T. Y.; Fayad, L.; Zhang, N.; Piha-Paul, S.; Woessner, R.; Nadella, M. V.; Lawson, D.; Reimer, C.; Jo, M. J.; Schmidt, J.; Xiao, X. K.; Greenlee, S.; Hung, G. N.; Yamashita, M.; Blakey, D. C.; Monia, B. P.; Macleod, A. R.; Kurzrock, R. |
| Abstract Title: | Preclinical pharmacology and clinical efficacy of AZD9150 (ISIS-STAT3Rx), a potent next-generation antisense oligonucleotide inhibitor of STAT3 |
| Meeting Title: | 105th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 74 |
| Issue: | 19 Suppl. |
| Meeting Dates: | 2014 Apr 5-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2014-10-01 |
| Language: | English |
| ACCESSION: | WOS:000349910205261 |
| DOI: | 10.1158/1538-7445.am2014-lb-227 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-227 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos |
